Headline:Investors who lost money with Humana Inc. (NYSE: HUM) shares should contact the Shareholders Foundation in connection with Lawsuit

Core Viewpoint - The ongoing lawsuit against Humana Inc. involves allegations of securities law violations, particularly regarding the company's assurances about healthcare demand and profitability amidst rising medical costs due to pent-up demand following COVID-19 restrictions [2][3]. Group 1: Lawsuit Background - A Humana investor filed a lawsuit in June 2024, claiming that the company misled investors about the impact of pent-up demand for healthcare services on its financial performance [2]. - The lawsuit alleges that Humana downplayed the pressures on its adjusted EPS from increased medical costs, contrary to its assurances that there was no significant pent-up demand affecting utilization rates [2]. Group 2: Legal Proceedings - A consolidated amended complaint was filed on November 20, 2024, and the defendants submitted a motion to dismiss the complaint on April 24, 2025 [3]. - Investors who purchased shares of Humana Inc. prior to July 2022 are encouraged to contact the Shareholders Foundation for potential options related to the lawsuit [1][3].